SlideShare una empresa de Scribd logo
1 de 7
Descargar para leer sin conexión
Biogen Idec Devika Salunke, Pragya Singh, Brendan Nichols, Rajat Kaushik, Renuka Gangakhedkar, Alex Sweeney
COMA COMPANY STRUCTURE
FINANCIAL STRUCTURE Total Revenue 4.71B Total Equity 5.4 B Operating income 1.24 B Total Assets 8.1B Net income  .89 B B= billion FY 2010 (consolidated)
CEO:  George A. Scangos CFO & Management : Paul Clancy VP of R&D:  Douglas Williams Regulatory:  Nadine Cohen The Brains and Goals Behind Biogen Idec Business Goals as of 2007: --  100,000 patients on TYSABRI(R) (natalizumab); Not yet met. --  More than 40% of the Company's revenue coming from its International business; Not yet met. --  Four new products and/or existing products  launched in new indications; Not yet met. --  Six programs in late-stage clinical development. Goal achieved.
Biogen Idec’s Drugs
Five Main Areas of Research ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

Similar a Biogenfinal

becton dickinson 2006AR
becton dickinson 2006ARbecton dickinson 2006AR
becton dickinson 2006ARfinance45
 
Q4 and FY 2017 Results
Q4 and FY 2017 ResultsQ4 and FY 2017 Results
Q4 and FY 2017 ResultsSanofi
 
Wolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year ResultsWolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year ResultsWolters Kluwer
 
Genetic Technologies Investor Presentation July 2022
Genetic Technologies Investor Presentation July 2022Genetic Technologies Investor Presentation July 2022
Genetic Technologies Investor Presentation July 2022RedChip Companies, Inc.
 
Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012Biocon
 
Sustaining innovation day 2017 presentation
Sustaining innovation day 2017 presentationSustaining innovation day 2017 presentation
Sustaining innovation day 2017 presentationSanofi
 
Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13Biocon
 
Project Report On M & A of Ranbaxy ltd. And Daiichi sankyo
Project Report On M & A of Ranbaxy ltd. And Daiichi sankyoProject Report On M & A of Ranbaxy ltd. And Daiichi sankyo
Project Report On M & A of Ranbaxy ltd. And Daiichi sankyoNikita Agarwal
 
Hem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87cr
Hem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87crHem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87cr
Hem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87crIndiaNotes.com
 
UBS Global Life Sciences Conference
UBS Global Life Sciences ConferenceUBS Global Life Sciences Conference
UBS Global Life Sciences ConferenceImpaxLaboratories
 
Can-Fite BioPharma - Investor Presentation December 2020
Can-Fite BioPharma - Investor Presentation December 2020Can-Fite BioPharma - Investor Presentation December 2020
Can-Fite BioPharma - Investor Presentation December 2020RedChip Companies, Inc.
 

Similar a Biogenfinal (20)

2006AR
2006AR2006AR
2006AR
 
becton dickinson 2006AR
becton dickinson 2006ARbecton dickinson 2006AR
becton dickinson 2006AR
 
2012111173629826
20121111736298262012111173629826
2012111173629826
 
2005ARa
2005ARa2005ARa
2005ARa
 
Q4 and FY 2017 Results
Q4 and FY 2017 ResultsQ4 and FY 2017 Results
Q4 and FY 2017 Results
 
Wolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year ResultsWolters Kluwer 2011 Half-Year Results
Wolters Kluwer 2011 Half-Year Results
 
Genetic Technologies Investor Presentation July 2022
Genetic Technologies Investor Presentation July 2022Genetic Technologies Investor Presentation July 2022
Genetic Technologies Investor Presentation July 2022
 
Ranbaxy
RanbaxyRanbaxy
Ranbaxy
 
Tpi feb 2013
Tpi feb 2013Tpi feb 2013
Tpi feb 2013
 
Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012Biocon AGM 2012 Presentation July 26, 2012
Biocon AGM 2012 Presentation July 26, 2012
 
Sustaining innovation day 2017 presentation
Sustaining innovation day 2017 presentationSustaining innovation day 2017 presentation
Sustaining innovation day 2017 presentation
 
Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13Biocon’s nine months revenue continues to deliver steady growth in fy13
Biocon’s nine months revenue continues to deliver steady growth in fy13
 
Project Report On M & A of Ranbaxy ltd. And Daiichi sankyo
Project Report On M & A of Ranbaxy ltd. And Daiichi sankyoProject Report On M & A of Ranbaxy ltd. And Daiichi sankyo
Project Report On M & A of Ranbaxy ltd. And Daiichi sankyo
 
Hem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87cr
Hem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87crHem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87cr
Hem recommend this pharma scrip on Q4FY15 operating profits of Rs495.87cr
 
UBS Global Life Sciences Conference
UBS Global Life Sciences ConferenceUBS Global Life Sciences Conference
UBS Global Life Sciences Conference
 
Can-Fite BioPharma - Investor Presentation December 2020
Can-Fite BioPharma - Investor Presentation December 2020Can-Fite BioPharma - Investor Presentation December 2020
Can-Fite BioPharma - Investor Presentation December 2020
 
Orgenesis Investor Corporate Presentation
Orgenesis Investor Corporate PresentationOrgenesis Investor Corporate Presentation
Orgenesis Investor Corporate Presentation
 
2007AR
2007AR2007AR
2007AR
 
2007AR
2007AR2007AR
2007AR
 
2007AR
2007AR2007AR
2007AR
 

Más de intro2biotech

Más de intro2biotech (6)

Presentation1
Presentation1Presentation1
Presentation1
 
Company Structure
Company StructureCompany Structure
Company Structure
 
Financial structure[2]
Financial structure[2]Financial structure[2]
Financial structure[2]
 
Company structure[1]
Company structure[1]Company structure[1]
Company structure[1]
 
Financial structure
Financial structureFinancial structure
Financial structure
 
Company structure
Company structureCompany structure
Company structure
 

Último

Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.ukaroemirsr
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakEditores1
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..dlewis191
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Reportamberjiles31
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursKaiNexus
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Lviv Startup Club
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarNathanielSchmuck
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toumarfarooquejamali32
 
NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023Steve Rader
 

Último (20)

Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
Investment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV IndustriesInvestment Opportunity for Thailand's Automotive & EV Industries
Investment Opportunity for Thailand's Automotive & EV Industries
 
7movierulz.uk
7movierulz.uk7movierulz.uk
7movierulz.uk
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerak
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
WAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdfWAM Corporate Presentation Mar 25 2024.pdf
WAM Corporate Presentation Mar 25 2024.pdf
 
Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..Team B Mind Map for Organizational Chg..
Team B Mind Map for Organizational Chg..
 
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
Boat Trailers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...
 
Project Brief & Information Architecture Report
Project Brief & Information Architecture ReportProject Brief & Information Architecture Report
Project Brief & Information Architecture Report
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, Ours
 
Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)Michael Vidyakin: Introduction to PMO (UA)
Michael Vidyakin: Introduction to PMO (UA)
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry Webinar
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
Lecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb toLecture_6.pptx English speaking easyb to
Lecture_6.pptx English speaking easyb to
 
NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023
 

Biogenfinal

  • 1. Biogen Idec Devika Salunke, Pragya Singh, Brendan Nichols, Rajat Kaushik, Renuka Gangakhedkar, Alex Sweeney
  • 3. FINANCIAL STRUCTURE Total Revenue 4.71B Total Equity 5.4 B Operating income 1.24 B Total Assets 8.1B Net income .89 B B= billion FY 2010 (consolidated)
  • 4. CEO: George A. Scangos CFO & Management : Paul Clancy VP of R&D: Douglas Williams Regulatory: Nadine Cohen The Brains and Goals Behind Biogen Idec Business Goals as of 2007: -- 100,000 patients on TYSABRI(R) (natalizumab); Not yet met. -- More than 40% of the Company's revenue coming from its International business; Not yet met. -- Four new products and/or existing products launched in new indications; Not yet met. -- Six programs in late-stage clinical development. Goal achieved.
  • 6.
  • 7.